News › Industry News, Patient Care

Benzene Found in Various Acne Products; Valisure Files Petition With FDA to Recall Treatments

March 12, 2024
Acne on face and chest

High levels of the cancer-causing chemical benzene were found in various benzoyl peroxide (BPO) acne products from major brands, including Proactiv, Clinique, Clearasil, and more.

Valisure LLC, an independent testing laboratory, filed a petition with the US Food and Drug Administration (FDA) on Tuesday, requesting a recall of treatments affected by elevated levels of the carcinogen in order to allow regulators to investigate.

Valisure tested 66 BPO products, including creams, lotions, gels, and washes that are available over the counter from main retailers or in prescription form. Currently, FDA guidelines allow up to 2 parts per million of benzene, and Valisure found acne products that contain up to 12 times the allowed amount. Additionally, the parts per million of benzene significantly increased when the acne products were tested at higher temperatures that were designed to replicate how the products can break down over time.

Read more at Dermatology Times >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • New Radiesse Research Highlights Deeper Extracellular Matrix Regeneration
    • Aesthetic Injector Academy Becomes Silver Vendor Affiliate with the American Med Spa Association
    • Medical Purchasing Resource Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Designed by Stax Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Just Digital Launches Aesthera Marketing, a Dedicated Agency for Med Spas and Aesthetic Practices